Study of the effects of bromocriptine on sexual impotence

B. Ambrosi, R. Bara, P. Travaglini, G. Weber, P. Beck Peccoz, M. Rondena, R. Elli, G. Faglia

Research output: Contribution to journalArticlepeer-review


Serum testosterone, prolactin, LH, FSH and plasma 17β-oestradiol levels were determined in forty-seven male patients with sexual impotence. Low testosterone values and slightly elevated prolactin levels were observed in 19% and 17% of cases, respectively. Since sexual function in the male seems to be controlled by both dopaminergic stimulatory and serotoninergic inhibitory mechanisms, bromocriptine was given orally to seventeen patients. As the preliminary results appeared encouraging, double blind study was undertaken in the other thirty patients. No appreciable difference in hormonal pattern was noted between bromocriptine and placebo treatment. As far as sexual function was concerned, good results were obtained in 52% of cases treated with bromocriptine and in 44% of patients given placebo.

Original languageEnglish
Pages (from-to)417-421
Number of pages5
JournalClinical Endocrinology
Issue number5
Publication statusPublished - 1977

ASJC Scopus subject areas

  • Endocrinology


Dive into the research topics of 'Study of the effects of bromocriptine on sexual impotence'. Together they form a unique fingerprint.

Cite this